{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T17:03:47Z","timestamp":1784567027787,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2023-JYB-JBZD-036"],"award-info":[{"award-number":["2023-JYB-JBZD-036"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004846","name":"Beijing University of Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004846","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374181"],"award-info":[{"award-number":["82374181"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.intimp.2025.114300","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T12:50:43Z","timestamp":1739796643000},"page":"114300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Triptolide combined with salvianolic acid B alleviates CCL4-induced liver fibrosis by suppressing the Th17\/IL-17A axis"],"prefix":"10.1016","volume":"150","author":[{"given":"Shiyuan","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlin","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongpeng","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.intimp.2025.114300_bb0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.intimp.2025.114300_bb0010","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2025.114300_bb0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.intimp.2025.114300_bb0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.intimp.2025.114300_bb0025","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.intimp.2025.114300_bb0030","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nri3623","article-title":"Liver fibrosis and repair: immune regulation of wound healing in a solid organ","volume":"14","author":"Pellicoro","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2025.114300_bb0035","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3389\/fimmu.2020.01142","article-title":"T cells in fibrosis and fibrotic diseases","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2025.114300_bb0040","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2012.05.049","article-title":"Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice","volume":"143","author":"Meng","year":"2012","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.intimp.2025.114300_bb0045","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.autrev.2018.06.008","article-title":"IL-17 and IL-17-producing cells and liver diseases, with focus on autoimmune liver diseases","volume":"17","author":"Beringer","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2025.114300_bb0050","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3389\/fimmu.2017.01195","article-title":"Immunity and Fibrogenesis: the role of Th17\/IL-17 Axis in HBV and HCV-induced chronic hepatitis and progression to cirrhosis","volume":"8","author":"Paquissi","year":"2017","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2025.114300_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2021.04.018","article-title":"PKM2-dependent metabolic skewing of hepatic Th17 cells regulates pathogenesis of non-alcoholic fatty liver disease","volume":"33","author":"Moreno-Fernandez","year":"2021","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.intimp.2025.114300_bb0060","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1501175","article-title":"Progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis is marked by a higher frequency of Th17 cells in the liver and an increased Th17\/resting regulatory T cell ratio in peripheral blood and in the liver","volume":"196","author":"Rau","year":"2016","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2025.114300_bb0065","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.131277","article-title":"Blockade of IL-17 signaling reverses alcohol-induced liver injury and excessive alcohol drinking in mice","volume":"5","author":"Xu","year":"2020","journal-title":"JCI Insight"},{"issue":"9","key":"10.1016\/j.intimp.2025.114300_bb0070","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/abbs\/gmt065","article-title":"Neutralization of interleukin-17 attenuates high fat diet-induced non-alcoholic fatty liver disease in mice","volume":"45","author":"Xu","year":"2013","journal-title":"Acta Biochim. Biophys. Sin. Shanghai"},{"issue":"7","key":"10.1016\/j.intimp.2025.114300_bb0075","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/ptr.3381","article-title":"Antifibrotic effects of triptolide on hepatic stellate cells and dimethylnitrosamine-intoxicated rats","volume":"25","author":"Chong","year":"2011","journal-title":"Phytother. Res."},{"key":"10.1016\/j.intimp.2025.114300_bb0080","doi-asserted-by":"crossref","first-page":"1032722","DOI":"10.3389\/fnut.2022.1032722","article-title":"Triptolide increases resistance to bile duct ligation-induced liver injury and fibrosis in mice by inhibiting RELB","volume":"9","author":"Yuan","year":"2022","journal-title":"Front. Nutr."},{"issue":"Pt B","key":"10.1016\/j.intimp.2025.114300_bb0085","article-title":"Triptolide attenuates CCL4-induced liver fibrosis by regulating the differentiation of CD4+ T cells in mice","volume":"125","author":"Jiang","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.114300_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110550","article-title":"Salvianolic acid B inhibits hepatic stellate cell activation and liver fibrosis by targeting PDGFR\u03b2","volume":"122","author":"Liu","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.114300_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154435","article-title":"Salvianolic acid B suppresses hepatic stellate cell activation and liver fibrosis by inhibiting the NF-\u03baB signaling pathway via miR-6499-3p\/LncRNA-ROR","volume":"107","author":"Wang","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.intimp.2025.114300_bb0100","article-title":"Salvianolic acid B inhibits autophagy and activation of hepatic stellate cells induced by TGF-\u03b21 by downregulating the MAPK pathway","volume":"13","author":"Jiang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114300_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155465","article-title":"Esculin inhibits hepatic stellate cell activation and CCl4-induced liver fibrosis by activating the Nrf2\/GPX4 signaling pathway","volume":"128","author":"Xu","year":"2024","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.intimp.2025.114300_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040875","article-title":"Liver fibrosis: mechanistic concepts and therapeutic perspectives","volume":"9","author":"Roehlen","year":"2020","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.intimp.2025.114300_bb0115","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","article-title":"Hepatic inflammatory responses in liver fibrosis","volume":"20","author":"Hammerich","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2025.114300_bb0120","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-061020-053702","article-title":"Cytokine regulation and function in T cells","volume":"39","author":"Dong","year":"2021","journal-title":"Annu. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2025.114300_bb0125","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/s41401-022-01044-9","article-title":"Salvianolic acid B suppresses hepatic fibrosis by inhibiting ceramide glucosyltransferase in hepatic stellate cells","volume":"44","author":"Li","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"issue":"5","key":"10.1016\/j.intimp.2025.114300_bb0130","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00204-015-1543-4","article-title":"Experimental models of liver fibrosis","volume":"90","author":"Yanguas","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.intimp.2025.114300_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116306","article-title":"Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula","volume":"309","author":"Zhao","year":"2023","journal-title":"J. Ethnopharmacol."},{"issue":"28","key":"10.1016\/j.intimp.2025.114300_bb0140","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aar7754","article-title":"Type 3 cytokines IL-17A and IL-22 drive TGF-\u03b2-dependent liver fibrosis","volume":"3","author":"Fabre","year":"2018","journal-title":"Sci. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2025.114300_bb0145","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/hep.25744","article-title":"Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice","volume":"56","author":"Kong","year":"2012","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.intimp.2025.114300_bb0150","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nri2586","article-title":"Structure and signalling in the IL-17 receptor family","volume":"9","author":"Gaffen","year":"2009","journal-title":"Nat. Rev. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925002905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925002905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T04:21:06Z","timestamp":1763785266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925002905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":30,"alternative-id":["S1567576925002905"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114300","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triptolide combined with salvianolic acid B alleviates CCL4-induced liver fibrosis by suppressing the Th17\/IL-17A axis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114300","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114300"}}